ロード中...
Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report
BACKGROUND: Portopulmonary hypertension (PPH) is a relatively rare but well-recognized complication of end-stage liver disease. Moderate or severe PPH (mean pulmonary artery pressure [mPAP] ≥ 35 mmHg) is usually a contraindication for liver transplantation due to high operation-related mortality. He...
保存先:
| 出版年: | Surg Case Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803166/ https://ncbi.nlm.nih.gov/pubmed/29417353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-018-0423-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|